Form 8.3 – [GLOBALDATA PLC – 01 05 2025] – (CGWL)
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3...
Read moreDetails
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated...
Read moreDetailsiBio Reports Fiscal Third Quarter 2025 Financial Results
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq:IBIO), today reported financial results for the third quarter ended...
Read moreDetailsTurnOnGreen, Inc. Reports Strong Electric Vehicle Charging Network Growth in 2024
MILPITAS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- TurnOnGreen, Inc. (OTC:TOGI) (“TurnOnGreen” or the “Company”), a developer and provider of...
Read moreDetailsNic Pouches Unveils New Loyalty Points Rewards System for All Customers
Edgware, Middlesex, May 02, 2025 (GLOBE NEWSWIRE) -- Nic Pouches, the UK’s trusted source for premium nicotine pouches, is happy...
Read moreDetailselectroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
Addition of Quell® Platform Broadens electroCore’s Bioelectronic Technology Portfolio and Accelerates Growth in Chronic Pain and Wellness MarketsROCKAWAY, N.J., May...
Read moreDetailsALK enters into neffy® co-promotion agreement in the USA
Co-promotion with ARS Pharma based on cost sharing and performance-based revenue sharing.ALK to accelerate build-up of its US paediatric sales...
Read moreDetailsBest Pay by Mobile Casino Sites in The UK 2025
CasinoTopsOnline.com has reviewed the UK online casino market which is experiencing a significant shift as pay-by-mobile casino sites gain traction...
Read moreDetailsIES Holdings Reports Fiscal 2025 Second Quarter Results
HOUSTON, May 02, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial...
Read moreDetailsTourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
– Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease remains on track for...
Read moreDetailsADVERTISEMENTS
